4//SEC Filing
Keefer David R 4
Accession 0001104659-21-010383
CIK 0001818844other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:54 PM ET
Size
7.5 KB
Accession
0001104659-21-010383
Insider Transaction Report
Form 4
Keefer David R
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-28$7.80/sh+1,602$12,496→ 7,808 total(indirect: By LLC) - Exercise/Conversion
Warrant to Purchase Common Stock
2021-01-28−1,602→ 0 total(indirect: By LLC)Exercise: $7.80From: 2020-12-16Exp: 2021-01-20→ Common Stock (1,602 underlying)
Footnotes (2)
- [F1]The securities are owned directly by Ethica Group, LLC ("Ethica"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.
- [F2]The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001825986
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 7:54 PM ET
- Size
- 7.5 KB